A. Conti

发表

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells

M. Colombo, L. De Cecco, D. Delia, 2018, Cell Death & Differentiation.

The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas

M. Giorgio, A. Sabò, B. Amati, 2016, Oncotarget.

Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1

M. El-Bahrawy, A. Montinaro, H. Walczak, 2013, Cell Death and Differentiation.

Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis.

J. Werner, K. Anderson, O. Sansom, 2015, Cancer cell.

Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity

M. Colombo, P. Seneci, D. Delia, 2013, Cell Death and Disease.

Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I: Synthesis.

F. Vasile, D. Potenza, L. Belvisi, 2012, Bioorganic & medicinal chemistry.

Lemur tyrosine kinase 2 (LMTK2) is a determinant of cell sensitivity to apoptosis by regulating the levels of the BCL2 family members.

M. Giacca, A. Bardelli, D. Delia, 2017, Cancer letters.

Oncogenic KRAS sensitizes premalignant, but not malignant cells, to Noxa-dependent apoptosis through the activation of the MEK/ERK pathway

A. Ashworth, A. Bardelli, P. Seneci, 2015, Oncotarget.

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells

M. Colombo, L. De Cecco, D. Delia, 2018, Cell Death & Differentiation.

Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis.

J. Werner, K. Anderson, O. Sansom, 2015, Cancer cell.

SPION-Smac mimetic nano-conjugates: putative pro-apoptotic agents in oncology.

P. Seneci, M. Rizzi, D. Lecis, 2014, Bioorganic & medicinal chemistry letters.